Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Effects of PDE4B inhibition on excessive weight gain-induced impairment in cognitive function in laboratory mice


   Faculty of Biological Sciences

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
Dr S Clapcote Dr Jamie Johnston  No more applications being accepted  Competition Funded PhD Project (European/UK Students Only)

About the Project

In humans, obesity impairs cognition and produces atrophy of brain regions associated with learning and memory. Individual cognitive performance declines with increases in body mass and energy consumption. These deficits can be observed throughout life, from childhood to late adulthood. Our lab has generated mice that have a catalytic mutant form of PDE4B (Y358C) with a decreased ability to hydrolyse cAMP. We previously found that these mice show enhanced learning and memory; enhanced long-term potentiation and less synaptic depression in hippocampal slices; increased dendritic spine density in the hippocampus and amygdala; and enhanced neurogenesis in the adult dentate gyrus (McGirr et al. 2016 Neuropsychopharmacology 41:1080-92). In this PhD project, you will explore the cellular and biochemical mechanisms that might underlie obesity-induced changes in brain volume and cognitive function. Specifically, you will use behavioural, electrophysiological, biochemical and histological techniques to investigate the effects of high-fat diet-induced obesity on cognitive function in wild-type mice compared with mice with the PDE4B¬Y358C mutation that was previously shown to cause cognitive enhancement in lean mice fed a standard rodent diet. These experiments will increase understanding of the cellular processes underlying cognitive decline in obesity and the effects of inhibition of PDE4B upon this phenomenon

Funding Notes

White Rose BBSRC Doctoral Training Partnership in Mechanistic Biology
4 year fully-funded programme of integrated research and skills training, starting Oct 2019:
• Research Council Stipend
• UK/EU Tuition Fees
• Conference allowance
• Research Costs

Requirements:
At least a 2:1 honours degree or equivalent. We welcome students with backgrounds in biological, chemical or physical sciences, or mathematical backgrounds with an interest in biological questions.
EU candidates require 3 years of UK residency in order to receive full studentship

Not all projects advertised will be funded; the DTP will appoint a limited number of candidates via a competitive process.

https://biologicalsciences.leeds.ac.uk/directory/research-opportunities

References

McGirr A, Lipina TV, Mun HS, Georgiou J, Al-Amri AH, Ng E, Zhai D, Elliott C, Cameron RT, Mullins JG, Liu F, Baillie GS, Clapcote SJ, Roder JC. Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition. Neuropsychopharmacology. 2016 Mar;41(4):1080-92. doi: 10.1038/npp.2015.240.

Titus DJ, Wilson NM, Freund JE, Carballosa MM, Sikah KE, Furones C, Dietrich WD, Gurney ME, Atkins CM. Chronic Cognitive Dysfunction after Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor. J Neurosci. 2016 Jul 6;36(27):7095-108. doi: 10.1523/JNEUROSCI.3212-15.2016.

How good is research at University of Leeds in Biological Sciences?


Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Where will I study?


Project supervisors

Career overview

Dr Steven Clapcote joined the University of Leeds as a Lecturer in Pharmacology in 2008. He obtained his PhD from the University of Liverpool. Following his doctoral studies, Dr Clapcote undertook postdoctoral appointments at several prestigious institutions, including the University of Oxford (Jesus College, 1998-2002), Mount Sinai Hospital in Toronto (2002-2007), and the University of Edinburgh (2007-2008). His research focuses on the identification, characterisation, and validation of novel drug targets for the treatment of chronic central nervous system (CNS) diseases. Dr Clapcote''s work involves identifying disease-associated mutations in DNA samples from human patients, studying their phenotypic effects, and testing novel treatments in animal models, with the aim of understanding the molecular basis of these diseases to aid in the development of improved therapies.


Research interests

Dr Clapcote''s research group focuses on the identification, characterisation, and validation of novel drug targets for the treatment of chronic central nervous system (CNS) diseases. They identify disease-associated mutations in DNA samples from human patients, study their phenotypic effects, and test novel treatments in animal models. The goal is to understand the molecular basis of these diseases and aid in the development of improved therapies. One of the current research projects includes the modulation of a neuromodulator, specifically insulin sensing in the basal forebrain.

View Dr Steven Clapcote's profile 
Career overview

Dr Jamie Johnston is an Associate Professor in Neuroscience at the School of Biomedical Sciences, University of Leeds. Dr Johnston holds a Ph.D. in Neuroscience and a B.Sc. in Pharmacology. Dr Johnston''s research focuses on understanding how the brain perceives and responds to the external world by studying the computations performed by neural circuits. This includes examining how these circuits extract relevant sensory features from stimuli and adapt to store new information. Dr Johnston employs a variety of advanced techniques in research, including multi-photon imaging, electrophysiology, optogenetics, and computational modelling. Dr Johnston is affiliated with the Neuroscience and Behaviour research group and is a member of the Society for Neuroscience and The Physiological Society.


Research interests

Dr Johnston''s research focuses on understanding how the brain perceives and responds to the external world. They study how neural circuits perform specific computations, such as extracting relevant sensory features of stimuli and how these circuits adapt to store new information. Dr Johnston employs a variety of advanced techniques, including multi-photon imaging, electrophysiology, optogenetics, and computational modelling, to explore the operations of neural circuits. Current research projects include investigating the role of microglia in Fragile X syndrome using an in vivo human induced pluripotent stem cell-based model, modulation of insulin sensing in the basal forebrain, and multisensory integration related to satiety and olfaction.

View Dr Jamie Johnston's profile